ConsortiEX Blog

Brandon Hartman

Recent Posts

ConsortiEX Soars to Support Dream Flights, and US Veterans

MILWAUKEE -- For many, flying in a plane can be a nerve-wracking experience. In fact, 1 in 6 people reports a fear so severe that it prevents them from flying entirely. But, for a handful of local Wisconsin Veterans, flying in an open-cockpit Stearman Biplane remained a lifelong dream. A dream they would soon achieve[...]

ConsortiEX Customer Spotlight | Cape Cod Healthcare

Milwaukee WI -- The latest edition of our Customer Spotlight series, where we with our partners to get their first hand experiences on the impact of ConsortiEX software and services on their operations, features Jim Mangan, RPh., MBA at Cape Cod Healthcare. More specifically, we spoke with Mangan on how Assure-Trak®[...]

ConsortiEX | ASHP Midyear 2023

Customer Spotlight | Indiana University Health (ISC)

FDA Issues Guidance Delaying Select Drug Supply Chain Security Act (DSCSA) Requirements

Milwaukee, WI – The FDA recently issued updated guidance for industry surrounding DSCSA and the upcoming requirement deadline. Passed in 2013, DSCSA aims to reduce counterfeit and illegitimate products from reaching dispensers, improving patient outcomes and securing the pharmacy supply chain. The 10-year rollout was[...]

ConsortiEX | ASHP Summer 2023

ConsortiEX is exhibiting at this year’s ASHP Summer Meeting in Baltimore, MD, from June 10-14! You can find us at Booth 615.

ConsortiEX Customer Spotlight | Advocate Aurora Health

The ConsortiEX Customer Spotlight series has historically been used to highlight the impact that the Assure-Trak® Compounding Management System has had on improving compliance documentation and workflow efficiency initiatives at both 503B Outsourcing Facilities and Health System pharmacies, showing the real-world[...]

ConsortiEX - 10 Years of Service

2023 marks a very special year for ConsortiEX, as we celebrate our 10th year of operations, and our 10th year of providing innovative service and solutions to the pharmacy community. Follow along each month as we recant our evolution from a small start-up into an industry leading DQSA Compliance Provider.

FDA Issues New Guidance on Suspect and Illegitimate Product

The FDA recently issued guidance on the definition of Suspect and Illegitimate Products, set forth in the Federal Food Drug and Cosmetic Act1. This guidance aims to assist trading partners in putting systems in place to identify and handle suspect and illegitimate products, meeting Drug Supply Chain Security Act[...]

Customer Spotlight | Conway Regional Medical Center

1 2

Topics

See all